CorMedix Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 7.64 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 595.49M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
Details
| Name | CorMedix Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 191 |
| Founded | 2006 |
| Ipo Date | 2010-03-25 |
| Ceo | Joseph Todisco |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US21900C3088 |
| Cusip | 21900C308 |
| Cik | 0001410098 |
| Sic | 2834 |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
Key executives
| Name | Title |
|---|---|
| Joseph Todisco MBA | Chief Executive Officer and Chairman of the Board of Directors |
| Elizabeth Masson-Hurlburt B.A. | Executive Vice President and Chief Operating and Commercial Officer |
| Kaufman Beth Zelnick Esq. | EVice President, Chief Legal and Compliance Officer and Corporate Secretary |
| Susan Blum | Executive Vice President and Chief Financial Officer |
| Beth Steinbrenner | SVice President and Chief Human Resource Officer |
Contact
| Address | 389 Interpace Pkwy, Suite 450, Parsippany, New Jersey 07054, United States |
| Phone | 908 517 9500 |
| Website | https://cormedix.com |